- Citations, last 5 years
- 60
- Works, last 5 years
- 6
- h-index
- 19
- Scientists listed
- 2
- Grants since 2016
- 9
Grants received
2025–2027 · research · R43
A Novel Approach to Eliminate Length Impurities for High-Quality mRNA Production
Hari Bhaskaran · US Biologic (United States) · funded by National Institutes of Health
2025–2027 · research · R41
Rapid and Ultra-Pure mRNA Production with Next-Generation RNA Polymerases
Hari Bhaskaran · US Biologic (United States) · funded by National Institutes of Health
2024–2025 · research · R43
A novel MICA/B based tumor-centric bispecific antibody that enhances NK cell activity in a hostile tumor microenvironment
Hemanta Baruah · US Biologic (United States) · funded by National Institutes of Health
2024–2025 · research · R42
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
Joshua Reynolds · US Biologic (United States) · funded by National Institutes of Health
2024–2026 · grant · Standard Grant
SBIR Phase I: Development of a Novel Platform for Cost-Efficient mRNA Production in Yeast
Hari Bhaskaran · US Biologic (United States) · funded by National Science Foundation
2024–2025 · research · R42
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
Joshua Reynolds · US Biologic (United States) · funded by National Institutes of Health
2024–2027 · research · R44
Development of Deep Mutational Scanning with Duplex Sequencing (DMS-DS) for anti-cancer drug evaluation and administration
Joshua Reynolds · US Biologic (United States) · funded by National Institutes of Health
2023–2024 · grant · Standard Grant
STTR Phase I: Biocontrol of Pythium pathogens in hydroponic greenhouses
Jigarkumar Patel · US Biologic (United States) · funded by National Science Foundation
2022–2024 · grant · Standard Grant
SBIR Phase I: Development of an Optical Biosensor to Facilitate Screening, Validation, and Development of Novel Drugs and their Biological Targets
Brandon Moyer · US Biologic (United States) · funded by National Science Foundation